Pharmaceutical and Specialty Chemical Companies.(Source : 201903 Annual Report Page No:28)About The company is into manufacturing chemical dyes and specialty intermediates for leading agrochemical and pharmaceutical companies in India.
Chemiesynth (Vapi) Limited has announced the publication of its unaudited financial results for the quarter ended June 30, 2025. The Board of Directors previously approved these results. This update informs shareholders about the public availability of the company's latest quarterly financial performance, fulfilling a standard disclosure requirement. Investors can now...
Chemiesynth (Vapi) Limited has provided a certificate confirming that all security dematerialization requests for the quarter were processed and reported to the relevant stock exchanges. The company’s registrar and transfer agent verified and canceled physical share certificates after successful dematerialization, updating the ownership records accordingly. There were no shares dematerialized...
Chemiesynth (Vapi) Limited has announced a board meeting on which it approved the audited financial results for the quarter and year ended March 31, 2025. The results have been published in English and Gujarati newspapers. This reflects the company’s compliance with disclosure requirements and keeps shareholders informed about its financial...
Chemiesynth (Vapi) Limited has confirmed its non-applicability of Regulation 24A of SEBI's Listing Obligations and Disclosure Requirements for the year ending March 31, 2025. The company's paid-up equity share capital is ₹3.07 crore, and its net worth is below ₹25 crore, exempting it from the requirement to submit a Secretarial...
